MAPT and Alzheimer disease: During the progression of Alzheimer’s disease, the amounts of total and soluble Tau protein progressively increase even before significant hyperphosphorylation or aggregation, suggesting an early imbalance of Tau cellular levels (Kurbatskaya et al., 2016; Han et al., 2017).